InsiderClue
Insiders · Profile

Crowley John F

Director at Entrada Therapeutics · Director at Intellia Therapeutics. Filing since 5 Oct 2021. CIK 0001400973

TRDA Entrada Therapeutics, Inc. Director · 1 trade NTLA Intellia Therapeutics, Inc. Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
TRDA Entrada Therapeutics, Inc.
12 Jan 2022
Director
Bought
5,000
$48.58K
opened
NTLA Intellia Therapeutics, Inc.
11 Oct 2021
Director
Sold, plan not stated
2,500
$298.88K
54.4%
NTLA Intellia Therapeutics, Inc.
5 Oct 2021
Director
Sold, plan not stated
10,000
$1.31M
82.7%
3 decisions on file.